We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$7.13B
AUM Growth
-$336M
(-4.5%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
48.37%
Holding
125
New
1
Increased
23
Reduced
62
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cytek Biosciences
CTKB
|
+$57.2M |
| 2 |
CryoPort
CYRX
|
+$48.1M |
| 3 |
Xometry
XMTR
|
+$43.6M |
| 4 |
nCino
NCNO
|
+$24.2M |
| 5 |
ENFN
Enfusion, Inc.
ENFN
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QuidelOrtho
QDEL
|
+$60.8M |
| 2 |
Manhattan Associates
MANH
|
+$58.2M |
| 3 |
Paycom
PAYC
|
+$45.5M |
| 4 |
Protolabs
PRLB
|
+$37.2M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
+$34.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 58.11% |
| 2 | Healthcare | 33.24% |
| 3 | Industrials | 6.94% |
| 4 | Materials | 0.73% |
| 5 | Consumer Discretionary | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Manhattan Associates
MANH
$12.5B
| $401M | 5.62% |
3,013,959
-429,877
| -12% | -$58.2M |
|
|
2
Paycom
PAYC
$10.4B
| $397M | 5.57% |
1,203,013
-132,260
| -10% | -$45.5M |
|
3
Tyler Technologies
TYL
$14.9B
| $386M | 5.41% |
1,110,551
-25,042
| -2% | -$9.31M |
|
4
Alarm.com
ALRM
$2.77B
| $372M | 5.22% |
5,737,440
-65,249
| -1% | -$4.48M |
|
5
AppFolio
APPF
$7.59B
| $330M | 4.63% |
3,155,516
-14,505
| -0.5% | -$1.48M |
|
6
Veeva Systems
VEEV
$44.5B
| $326M | 4.57% |
1,975,158
-1,099
| -0.1% | -$220K |
|
7
Repligen
RGEN
$9.46B
| $326M | 4.56% |
1,740,034
-17,013
| -1% | -$3.59M |
|
|
ABMD
8
DELISTED
Abiomed Inc
ABMD
| $310M | 4.34% |
1,260,466
-1,993
| -0.2% | -$538K |
|
9
Cognex
CGNX
$10.5B
| $304M | 4.26% |
7,335,851
+240,900
| +3% | +$10.9M |
|
10
Datadog
DDOG
$76.5B
| $298M | 4.18% |
3,361,984
+30
| +0% | +$3.02K |
|
|
ANSS
11
DELISTED
Ansys
ANSS
| $272M | 3.81% |
1,224,710
-9,013
| -0.7% | -$2.3M |
|
12
Bio-Techne
TECH
$11.4B
| $234M | 3.28% |
3,293,212
-65,136
| -2% | -$5.63M |
|
|
SMAR
13
DELISTED
Smartsheet Inc.
SMAR
| $220M | 3.09% |
6,412,165
-435,738
| -6% | -$14.8M |
|
14
Guidewire Software
GWRE
$13.5B
| $179M | 2.51% |
2,912,016
+62,389
| +2% | +$4.51M |
|
15
Vericel Corp
VCEL
$2.06B
| $172M | 2.41% |
7,409,690
+61,803
| +0.8% | +$1.69M |
|
|
16
Xometry
XMTR
$5.3B
| $161M | 2.26% |
2,839,436
+933,270
| +49% | +$43.6M |
|
17
OrthoPediatrics
KIDS
$585M
| $156M | 2.19% |
3,381,034
+10,930
| +0.3% | +$536K |
|
18
Glaukos
GKOS
$10.5B
| $152M | 2.13% |
2,859,654
+209,589
| +8% | +$10.8M |
|
19
Helios Technologies
HLIO
$2.36B
| $149M | 2.08% |
2,935,784
+73,829
| +3% | +$4.46M |
|
|
CYBR
20
DELISTED
CyberArk
CYBR
| $147M | 2.06% |
981,213
-136,797
| -12% | -$19.5M |
|
|
21
CryoPort
CYRX
$801M
| $144M | 2.02% |
5,905,250
+1,397,616
| +31% | +$48.1M |
|
22
Q2 Holdings
QTWO
$3.87B
| $144M | 2.01% |
4,459,241
-413,199
| -8% | -$16.8M |
|
|
PRO
23
DELISTED
PROS Holdings
PRO
| $129M | 1.81% |
5,219,077
-11,221
| -0.2% | -$272K |
|
24
Neogen
NEOG
$2.58B
| $122M | 1.71% |
8,739,338
-36,856
| -0.4% | -$742K |
|
|
25
nCino
NCNO
$2.44B
| $113M | 1.58% |
3,307,228
+717,532
| +28% | +$24.2M |
|
Similar funds
HC
TLP
ISWM
PT
FGWP
PCA
FNBOMD
TPWM
Brown Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Brown Capital Management held 125 positions worth $7.13B, down 4.5% from $7.47B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 1.6%. Brown Capital Management opened 1 new position and exited 1, leaving the 125-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 58% of assets, up from 55% a quarter earlier, followed by Healthcare and Industrials.
- Brown Capital Management's largest Q3 2022 buy was Cytek Biosciences: 4,406,461 shares worth $64.9M.
- Brown Capital Management added most to CryoPort in Q3 2022, an estimated $48.1M increase.
- Brown Capital Management's biggest Q3 2022 reduction was QuidelOrtho, cutting an estimated $60.8M.
- Brown Capital Management fully exited DMC Global in Q3 2022, selling an estimated $31.8M.
- Brown Capital Management's ten largest holdings make up 48% of its $7.13B portfolio in Q3 2022.
- Brown Capital Management opened 1 new position and closed 1 in Q3 2022.
- Brown Capital Management's portfolio value fell 4.5% quarter-over-quarter to $7.13B.
Based on Brown Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.